| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina
Requests for reprints: Iris J. Edwards, Ph.D, Department of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157. Phone: 336-716-2677; Fax: 33-716-6279; E-mail: iedwards{at}wfubmc.edu.
Human epidemiologic studies and animal model studies support a role for n-3 polyunsaturated fatty acids (n-3 PUFA) in prevention or inhibition of breast cancer. However, mechanisms for this protection remain unclear. Syndecan-1 is a heparan sulfate proteoglycan, expressed on the surface of mammary epithelial cells and known to regulate many biological processes, including cytoskeletal organization, growth factor signaling, and cell-cell adhesion. We studied effects of n-3 PUFA on syndecan-1 expression in human mammary cell lines. PUFA were delivered to cells by low-density lipoproteins (LDL) isolated from the plasma of monkeys fed diets enriched in fish oil (n-3 PUFA) or linoleic acid (n-6 PUFA). Proteoglycan synthesis was measured by incorporation of [35S]-sodium sulfate. No effect of either LDL was observed in nontumorigenic MCF-10A cells, whereas in MCF-7 breast cancer cells, treatment with n-3enriched LDL but not n-6enriched LDL resulted in significantly greater synthesis of a proteoglycan identified by immunoprecipitation as syndecan-1. Using real-time reverse transcription-PCR (RT-PCR), it was shown that n-3enriched LDL significantly increased the expression of syndecan-1 mRNA in a dose-dependent manner and maximal effective time at 8 hours of treatment. The effect was mimicked by an agonist for peroxisome proliferator-activated receptor
(PPAR
) and eliminated by the presence of PPAR
antagonist suggesting a role for PPAR
in syndecan enhancement. Our studies show that n-3 LDL modifies the production of syndecan-1 in human breast cancer cells and suggest that biological processes regulated by syndecan-1 may be modified through LDL delivery of n-3 PUFA.
This article has been cited by other articles:
![]() |
I. J. Edwards, H. Sun, Y. Hu, I. M. Berquin, J. T. O'Flaherty, J. M. Cline, L. L. Rudel, and Y. Q. Chen In Vivo and in Vitro Regulation of Syndecan 1 in Prostate Cells by n-3 Polyunsaturated Fatty Acids J. Biol. Chem., June 27, 2008; 283(26): 18441 - 18449. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun, I. M. Berquin, R. T. Owens, J. T. O'Flaherty, and I. J. Edwards Peroxisome Proliferator-Activated Receptor {gamma}-Mediated Up-regulation of Syndecan-1 by n-3 Fatty Acids Promotes Apoptosis of Human Breast Cancer Cells Cancer Res., April 15, 2008; 68(8): 2912 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Allred, D. R. Talbert, R. C. Southard, X. Wang, and M. W. Kilgore PPAR{gamma}1 as a Molecular Target of Eicosapentaenoic Acid in Human Colon Cancer (HT-29) Cells J. Nutr., February 1, 2008; 138(2): 250 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Freitas, V. F. Vilas-Boas, D. C. Pimenta, V. Loureiro, M. A. Juliano, M. R. Carvalho, J. J.V. Pinheiro, A. C.M. Camargo, A. S. Moriscot, M. P. Hoffman, et al. SIKVAV, a Laminin {alpha}1-Derived Peptide, Interacts with Integrins and Increases Protease Activity of a Human Salivary Gland Adenoid Cystic Carcinoma Cell Line through the ERK 1/2 Signaling Pathway Am. J. Pathol., July 1, 2007; 171(1): 124 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Sauer, R. T. Dauchy, D. E. Blask, J. A. Krause, L. K. Davidson, and E. M. Dauchy Eicosapentaenoic Acid Suppresses Cell Proliferation in MCF-7 Human Breast Cancer Xenografts in Nude Rats via a Pertussis Toxin-Sensitive Signal Transduction Pathway J. Nutr., September 1, 2005; 135(9): 2124 - 2129. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |